Discover and read the best of Twitter Threads about #site4444
Most recents (2)
☑️ Jikkyleaks
HOLY CRAP!
Two sites stand out from the #pfizerdocuments randomization log as major anomalies....
Site 1231 and Site 4444
You are not going to believe this.....
@AaronSiriSG @fynn_fan @ClareCraigPath @profnfenton
May 9, 2022
HOLY CRAP!
Two sites stand out from the #pfizerdocuments randomization log as major anomalies....
Site 1231 and Site 4444
You are not going to believe this.....
@AaronSiriSG @fynn_fan @ClareCraigPath @profnfenton
May 9, 2022
☑️ Jikkyleaks
The biggest recruiter by far is site 1231.
In Argentina. Well of course, for a joint German-American drug where else?
Site 1231 recruited 4501 patients.
That is 10% of the patients AT ONE SITE.
ALL 4501 patients were recruited in 3 weeks.
WOW!
The biggest recruiter by far is site 1231.
In Argentina. Well of course, for a joint German-American drug where else?
Site 1231 recruited 4501 patients.
That is 10% of the patients AT ONE SITE.
ALL 4501 patients were recruited in 3 weeks.
WOW!
☑️ Jikkyleaks
This is site 1231 from the @ICANdecide log
Recognise the name?
We'll come back to him in a sec....
This is site 1231 from the @ICANdecide log
Recognise the name?
We'll come back to him in a sec....
" Listing of Subjects Withdrawn From the Study"
phmpt.org/wp-content/upl…
first two pages tell us that no patients of the phase 1 trial discontinued between doses. however, the 100ug data was not used in the calculations, despite the participants being boostered with a 10ug dose..
phmpt.org/wp-content/upl…
first two pages tell us that no patients of the phase 1 trial discontinued between doses. however, the 100ug data was not used in the calculations, despite the participants being boostered with a 10ug dose..
.., because the original 100ug dose had a shit safety profile! as for the first table, could it be referring to the bnt162b1 cohort, whose data also wasn't used?
so phase 2, the 180/180 group, only had one withdrawal? it appears so, see linked tweet#1
however, how did they manage so much better dose1+dose2 compliance compared to bnt162-01 b2 group and phase 3, as we're about to see?
however, how did they manage so much better dose1+dose2 compliance compared to bnt162-01 b2 group and phase 3, as we're about to see?
